Wajcman Henri, Galactéros Frederic
INSERM U654, Bases Moléculaire et Cellulaires des Malades Génétiques, Hôpital Henri Mondor, Créteil, France.
Hemoglobin. 2005;29(2):91-106.
This review brings some new insights on erythrocytosis of genetic origin related to problems of oxygen delivery by hemoglobin (Hb). A few molecular mechanisms are individualized among the about 100 Hb variants that cause compensatory erythrocytosis. The most frequently observed structural modifications are localized in the alpha1beta2 interface, or at the C-terminal. They impair formation of a stable T state. Others mutations modify directly or indirectly the surrounding of the heme and the site where oxygen binds. A special interest is brought to the dose effect considering the possibility for formation of hybrid tetramers with altered oxygen binding properties. Homozygous cases, and patients who are compound heterozygotes for a high oxygen affinity Hb and a thalassemia (thal), are discussed. Several examples are provided, specially documented for Hb Olympia [beta20(B2)Val --> Met] and Hb Saint Nazaire [beta103(G5)Phe --> Ile]. Other mechanisms leading to erythrocytosis are discussed, and finally, an algorithm is proposed for etiological diagnosis.
本综述对与血红蛋白(Hb)氧输送问题相关的遗传性红细胞增多症带来了一些新见解。在约100种导致代偿性红细胞增多症的Hb变体中,确定了一些分子机制。最常观察到的结构修饰位于α1β2界面或C末端。它们会损害稳定T态的形成。其他突变直接或间接改变血红素周围环境以及氧结合位点。考虑到形成具有改变的氧结合特性的杂合四聚体的可能性,对剂量效应给予了特别关注。讨论了纯合病例以及携带高氧亲和力Hb和地中海贫血(thal)的复合杂合子患者。提供了几个实例,特别是针对Hb奥林匹亚[β20(B2)缬氨酸→甲硫氨酸]和Hb圣纳泽尔[β103(G5)苯丙氨酸→异亮氨酸]的详细记录。还讨论了导致红细胞增多症的其他机制,最后提出了病因诊断算法。